Literature DB >> 11263602

Predictors of diffuse and aggressive intra-stent restenosis.

S L Goldberg1, A Loussararian, J De Gregorio, C Di Mario, R Albiero, A Colombo.   

Abstract

OBJECTIVES: This study was performed to investigate the causes of diffuse and aggressive intra-stent restenosis.
BACKGROUND: Although restenosis is usually considered to be a dichotomous variable, there is clinical relevance to the severity of restenosis. It is not known which variables are predictive of diffuse or aggressive intra-stent restenosis.
METHODS: A consecutive series of 456 coronary lesions with in-stent restenosis was evaluated for the type of restenosis using quantitative coronary angiography. Restenosis was defined as > or = 50% diameter stenosis at follow-up angiography, diffuse restenosis as a follow-up lesion length > or = 10 mm and aggressive restenosis as either an increase in lesion length from the original lesion or a restenotic narrowing tighter than the original. Clinical, anatomic and procedural characteristics were evaluated for lesions associated with these types of restenosis.
RESULTS: Diffuse restenosis was associated with a smaller reference artery diameter, longer lesion length, female gender, longer stent length and the use of coil stents. Aggressive restenosis was more common in women, with the use of Wallstents and with long stent to lesion length ratios. Aggressive restenosis occurred earlier and was more closely associated with symptoms and myocardial infarctions than nonaggressive restenotic lesions.
CONCLUSIONS: Markers for diffuse restenosis were also important markers for the presence of any restenosis. A long stent to lesion length ratio is an important marker for aggressive restenosis. When severe forms of in-stent restenosis occur, they tend to present earlier and with more symptoms, including myocardial infarction. More careful consideration of the type of in-stent restenosis may aid in identifying when alternative strategies may be useful.

Entities:  

Mesh:

Year:  2001        PMID: 11263602     DOI: 10.1016/s0735-1097(01)01107-x

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  16 in total

1.  Characterizing the spectrum of in-stent restenosis: implications for contemporary treatment.

Authors:  Gordon E Pate; May Lee; Karin Humphries; Eric Cohen; Robert Lowe; Rebecca S Fox; Robert Teskey; Christopher E Buller
Journal:  Can J Cardiol       Date:  2006-12       Impact factor: 5.223

2.  Corrosion resistance studies on grain-boundary etched drug-eluting stents.

Authors:  Ralf Rettig; Julia Kunze; Michael Stöver; Erich Wintermantel; Sannakaisa Virtanen
Journal:  J Mater Sci Mater Med       Date:  2007-02-03       Impact factor: 3.896

3.  Nanomedicine: Addressing Cardiovascular Disease and Cardiovascular Tissue Regeneration.

Authors:  Rebekah A Neal; Olugbemisola Oredein-McCoy; Edward A Botchwey
Journal:  Curr Bioact Compd       Date:  2009

4.  Nitinol Carbofilm coated stents for peripheral applications: study in the porcine model.

Authors:  M Prunotto; C Isaia; M A Gatti; E Monari; E Pasquino; M Galloni
Journal:  J Mater Sci Mater Med       Date:  2005-12       Impact factor: 3.896

Review 5.  Understanding and managing in-stent restenosis: a review of clinical data, from pathogenesis to treatment.

Authors:  Dario Buccheri; Davide Piraino; Giuseppe Andolina; Bernardo Cortese
Journal:  J Thorac Dis       Date:  2016-10       Impact factor: 2.895

6.  Does a well developed collateral circulation predispose to restenosis after percutaneous coronary intervention? An intravascular ultrasound study.

Authors:  D Perera; P Postema; R Rashid; S Patel; L Blows; M Marber; S Redwood
Journal:  Heart       Date:  2005-10-10       Impact factor: 5.994

7.  Shortening the stent length reduces restenosis with bare metal stents: matched pair comparison of short stenting and conventional stenting.

Authors:  U Dietz; N Holz; C Dauer; H Lambertz
Journal:  Heart       Date:  2005-05-09       Impact factor: 5.994

8.  In-stent stenosis as a delayed complication of neuroform stent-supported coil embolization of an incidental carotid terminus aneurysm.

Authors:  David Fiorella; Felipe C Albuquerque; Vivek R Deshmukh; Cameron G McDougall
Journal:  AJNR Am J Neuroradiol       Date:  2004 Nov-Dec       Impact factor: 3.825

9.  Enhancement in anti-proliferative effects of paclitaxel in aortic smooth muscle cells upon co-administration with ceramide using biodegradable polymeric nanoparticles.

Authors:  Dipti Deshpande; Harikrishna Devalapally; Mansoor Amiji
Journal:  Pharm Res       Date:  2008-05-15       Impact factor: 4.200

Review 10.  Nanoparticulate carriers for the treatment of coronary restenosis.

Authors:  Luis Brito; Mansoor Amiji
Journal:  Int J Nanomedicine       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.